BMB Reports

생화학분자생물학회 (Korean Society for Biochemistry and Molecular Biology)
권호 표지
DOI QR코드

DOI QR Code

Lysophosphatidylcholine aggravates contact hypersensitivity by promoting neutrophil infiltration and IL17 expression

  • Song, Mi Hye (Department of Pathology, Hallym University College of Medicine) ;
  • Gupta, Anupriya (Department of Pathology, Hallym University College of Medicine) ;
  • Kim, Hye One (Department of Dermatology, Kangnam Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Oh, Kwonik (Department of Pathology, Hallym University College of Medicine)
  • 투고 : 2020.09.08
  • 심사 : 2020.11.04
  • 발행 : 2021.04.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Lysophosphatidylcholine (LPC) is a bioactive lysolipid known to contribute to the development of lung allergic diseases. However, it remains unknown whether LPC possesses proinflammatory properties in the skin as well. Here, we investigated this issue by injection of LPC into the murine contact hypersensitivity (CHS) model induced by 2,4-dinitrofluorobenzene (DNFB). LPC increased the expression of IL17, recruited more neutrophils, and eventually aggravated the CHS in the skins. Moreover, the effects of LPC diminished after neutralizing IL17 or depleting neutrophils. Mechanistically, LPC upregulated not only IL17 but also CXCL1 and CXCL2 in a G2A-dependent manner. Taken together, our study demonstrated that the upregulation of LPC could contribute to allergic skin inflammation by increasing IL17 expression and neutrophil recruitment via G2A receptor.

키워드

과제정보

This work was supported by NRF of Korea (2018R1D1A1B0704642813), Hallym University (H20160646) and Korea Healthcare R&D project (HI17C0597).

참고문헌

  1. Kaplan DH, Igyarto BZ and Gaspari AA (2012) Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol 12, 114-124 https://doi.org/10.1038/nri3150
  2. Honda T, Egawa G, Grabbe S and Kabashima K (2013) Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis. J Invest Dermatol 133, 303-315 https://doi.org/10.1038/jid.2012.284
  3. Weber FC, Nemeth T, Csepregi JZ et al (2015) Neutrophils are required for both the sensitization and elicitation phase of contact hypersensitivity. J Exp Med 212, 15-22 https://doi.org/10.1084/jem.20130062
  4. Rafei-Shamsabadi DA, van de Poel S, Dorn B et al (2018) Lack of type 2 innate lymphoid cells promotes a type I-driven increased immune response in contact hypersensitivity. J Invest Dermatol 138, 1962-1972 https://doi.org/10.1016/j.jid.2018.03.001
  5. Jiang X, Park CO, Geddes Sweeney J, Yoo MJ, Gaide O and Kupper TS (2017) Dermal gammadelta T cells do not freely re-circulate out of skin and produce IL-17 to promote neutrophil infiltration during primary contact hypersensitivity. PLoS One 12, e0169397 https://doi.org/10.1371/journal.pone.0169397
  6. Nielsen MM, Lovato P, MacLeod AS et al (2014) IL-1beta-dependent activation of dendritic epidermal T cells in contact hypersensitivity. J Immunol 192, 2975-2983 https://doi.org/10.4049/jimmunol.1301689
  7. Shimizuhira C, Otsuka A, Honda T et al (2014) Natural killer T cells are essential for the development of contact hypersensitivity in BALB/c mice. J Invest Dermatol 134, 2709-2718 https://doi.org/10.1038/jid.2014.200
  8. Kim HS, Lee MB, Lee D et al (2019) The regulatory B cell-mediated peripheral tolerance maintained by mast cell IL-5 suppresses oxazolone-induced contact hypersensitivity. Sci Adv 5, eaav8152 https://doi.org/10.1126/sciadv.aav8152
  9. Law SH, Chan ML, Marathe GK, Parveen F, Chen CH and Ke LY (2019) An updated review of lysophosphatidylcholine metabolism in human diseases. Int J Mol Sci 20, 1149 https://doi.org/10.3390/ijms20051149
  10. Liu P, Zhu W, Chen C et al (2020) The mechanisms of lysophosphatidylcholine in the development of diseases. Life Sci 247, 117443 https://doi.org/10.1016/j.lfs.2020.117443
  11. Fuchs B, Schiller J, Wagner U, Hantzschel H and Arnold K (2005) The phosphatidylcholine/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: investigations by 31P NMR and MALDITOF MS. Clin Biochem 38, 925-933 https://doi.org/10.1016/j.clinbiochem.2005.06.006
  12. Kabarowski JH (2009) G2A and LPC: regulatory functions in immunity. Prostaglandins Other Lipid Mediat 89, 73-81 https://doi.org/10.1016/j.prostaglandins.2009.04.007
  13. Yoder M, Zhuge Y, Yuan Y et al (2014) Bioactive lysophosphatidylcholine 16:0 and 18:0 are elevated in lungs of asthmatic subjects. Allergy Asthma Immunol Res 6, 61-65 https://doi.org/10.4168/aair.2014.6.1.61
  14. Arbibe L, Koumanov K, Vial D et al (1998) Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction. J Clin Invest 102, 1152-1160 https://doi.org/10.1172/JCI3236
  15. Zhuge Y, Yuan Y, van Breemen R et al (2014) Stimulated bronchial epithelial cells release bioactive lysophosphatidylcholine 16:0, 18:0, and 18:1. Allergy Asthma Immunol Res 6, 66-74 https://doi.org/10.4168/aair.2014.6.1.66
  16. Bansal P, Gaur SN and Arora N (2016) Lysophosphatidylcholine plays critical role in allergic airway disease manifestation. Sci Rep 6, 27430 https://doi.org/10.1038/srep27430
  17. Yan JJ, Jung JS, Lee JE et al (2004) Therapeutic effects of lysophosphatidylcholine in experimental sepsis. Nat Med 10, 161-167 https://doi.org/10.1038/nm989
  18. Hong CW, Kim TK, Ham HY et al (2010) Lysophosphatidylcholine increases neutrophil bactericidal activity by increasement of azurophil granule-phagosome fusion via glycine. GlyR alpha 2/TRPM2/p38 MAPK signaling. J Immunol 184, 4401-4413 https://doi.org/10.4049/jimmunol.0902814
  19. Lee HJ, Ko HJ, Song DK and Jung YJ (2018) Lysophosphatidylcholine promotes phagosome maturation and regulates inflammatory mediator production by means of the protein kinase A-phosphatidylinositol 3 kinase-p38 mitogenactivated protein kinase signaling pathway during mycobacterium tuberculosis infection in mouse macrophages. Front Immunol 9, 920 https://doi.org/10.3389/fimmu.2018.00920
  20. Zhu X, Learoyd J, Butt S et al (2007) Regulation of eosinophil adhesion by lysophosphatidylcholine via a non-storeoperated Ca2+ channel. Am J Respir Cell Mol Biol 36, 585-593 https://doi.org/10.1165/rcmb.2006-0391OC
  21. Fox LM, Cox DG, Lockridge JL et al (2009) Recognition of lyso-phospholipids by human natural killer T lymphocytes. PLoS Biol 7, e1000228 https://doi.org/10.1371/journal.pbio.1000228
  22. Maricic I, Girardi E, Zajonc DM and Kumar V (2014) Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease. J Immunol 193, 4580-4589 https://doi.org/10.4049/jimmunol.1400699
  23. Hasegawa H, Lei J, Matsumoto T, Onishi S, Suemori K and Yasukawa M (2011) Lysophosphatidylcholine increases the suppressive function of human naturally occurring regulatory T cells by means of TGF-beta production. Biochem Biophys Res Commun 415, 526-531 https://doi.org/10.1016/j.bbrc.2011.10.119
  24. Berdyshev E, Goleva E, Bronova I et al (2018) Lipid abnormalities in atopic skin are driven by type 2 cytokines. JCI Insight 3, e98006 https://doi.org/10.1172/jci.insight.98006
  25. Quinn MT, Parthasarathy S and Steinberg D (1988) Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci U S A 85, 2805-2809 https://doi.org/10.1073/pnas.85.8.2805
  26. Hattori T, Obinata H, Ogawa A et al (2008) G2A plays proinflammatory roles in human keratinocytes under oxidative stress as a receptor for 9-hydroxyoctadecadienoic acid. J Invest Dermatol 128, 1123-1133 https://doi.org/10.1038/sj.jid.5701172
  27. Paust S, Gill HS, Wang BZ et al (2010) Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigenspecific memory of haptens and viruses. Nat Immunol 11, 1127-1135 https://doi.org/10.1038/ni.1953
  28. Ye P, Rodriguez FH, Kanaly S et al (2001) Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194, 519-527 https://doi.org/10.1084/jem.194.4.519
  29. Miyamoto M, Prause O, Sjostrand M, Laan M, Lotvall J and Linden A (2003) Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol 170, 4665-4672 https://doi.org/10.4049/jimmunol.170.9.4665
  30. Sun D, Novotny M, Bulek K, Liu C, Li X and Hamilton T (2011) Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicingregulatory factor SF2 (ASF). Nat Immunol 12, 853-860 https://doi.org/10.1038/ni.2081
  31. Geha M, Tsokos MG, Bosse RE et al (2017) IL-17A produced by innate lymphoid cells is essential for intestinal ischemia-reperfusion injury. J Immunol 199, 2921-2929 https://doi.org/10.4049/jimmunol.1700655
  32. Le LQ, Kabarowski JH, Weng Z et al (2001) Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity 14, 561-571 https://doi.org/10.1016/S1074-7613(01)00145-5
  33. Kern K, Schafer SMG, Cohnen J et al (2018) The G2A receptor controls polarization of macrophage by determining their localization within the inflamed tissue. Front Immunol 9, 2261 https://doi.org/10.3389/fimmu.2018.02261
  34. Frasch SC, McNamee EN, Kominsky D et al (2016) G2A signaling dampens colitic inflammation via production of IFN-gamma. J Immunol 197, 1425-1434 https://doi.org/10.4049/jimmunol.1600264
  35. Obinata H and Izumi T (2009) G2A as a receptor for oxidized free fatty acids. Prostaglandins Other Lipid Mediat 89, 66-72 https://doi.org/10.1016/j.prostaglandins.2008.11.002
  36. Li HM, Jang JH, Jung JS et al (2019) G2A protects mice against sepsis by modulating kupffer cell activation: cooperativity with adenosine receptor 2b. J Immunol 202, 527-538 https://doi.org/10.4049/jimmunol.1700783
  37. Engeman T, Gorbachev AV, Kish DD and Fairchild RL (2004) The intensity of neutrophil infiltration controls the number of antigen-primed CD8 T cells recruited into cutaneous antigen challenge sites. J Leukoc Biol 76, 941-949 https://doi.org/10.1189/jlb.0304193
  38. He D, Wu L, Kim HK, Li H, Elmets CA and Xu H (2009) IL-17 and IFN-gamma mediate the elicitation of contact hypersensitivity responses by different mechanisms and both are required for optimal responses. J Immunol 183, 1463-1470 https://doi.org/10.4049/jimmunol.0804108
  39. Kim G, Jeong H, Youn H et al (2020) Anti-inflammatory mechanisms of suppressors of cytokine signaling target ROS via NRF-2/thioredoxin induction and inflammasome activation in macrophages. BMB Rep 53, 640-645 https://doi.org/10.5483/BMBRep.2020.53.12.161